Banco Bilbao Vizcaya Argentaria S.A. Sells 5,805 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Banco Bilbao Vizcaya Argentaria S.A. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 13.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,555 shares of the medical equipment provider's stock after selling 5,805 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Intuitive Surgical were worth $19,136,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $25,000. Hurley Capital LLC purchased a new position in Intuitive Surgical in the fourth quarter worth $28,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Finally, Summit Securities Group LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 810 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 30,819 shares of company stock valued at $15,937,836 in the last ninety days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded down $0.71 during midday trading on Tuesday, hitting $513.30. The company had a trading volume of 489,846 shares, compared to its average volume of 2,201,878. The stock has a market capitalization of $182.83 billion, a P/E ratio of 80.10, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52-week low of $367.39 and a 52-week high of $616.00. The company has a 50 day moving average of $510.03 and a 200 day moving average of $533.26.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the firm posted $1.50 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on ISRG shares. Erste Group Bank downgraded shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Royal Bank of Canada decreased their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. UBS Group upped their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Finally, CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target for the company. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.